About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Tyrosine Allergoid Paediatric and Adult Study | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingNCT05186025

Tyrosine Allergoid Paediatric and Adult Study

The primary objective of this 5-year study is to demonstrate non-inferiority of children compared to adults by exploring long-term effectiveness after treatment with TA Bäume (trees) and TA Gräser (gr...

Lead sponsor: Allergy Therapeutics•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Allergy Therapeutics

Collaborators

Bencard Allergie GmbH

Age

5 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients from 5 years of age who are treated with TA Gräser top or TA Bäume top due to rhinitis, conjunctivitis and/or mild to moderate bronchial asthma, which are caused by an IgE-mediated allergy to grass and rye pollen or birch, alder and hazel pollen according to the respective SmPC.
•Patients will only be included in this study after the decision on the treatment has been made.

Exclusion Criteria

•History of allergen-specific immunotherapy (SIT) for trees or grass within the last 5 years
•If it´s intended to treat the patient with only a preseasonal therapy
•A patient should also not be included in the presence of any of the conditions listed in the respective SmPC

Related studies

RECRUITINGPhase 2

Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

NCT05008965 · Allergic Asthma

RECRUITINGPhase 3

A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)

NCT04699604 · Allergic Asthma

RECRUITINGPhase 2

Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis

NCT06686472 · Allergic Conjunctivitis

Enrolling By InvitationEARLY Phase 1

Asthma Inflammation Research

NCT01536522 · Asthma, Allergic Asthma, and more

Enrolling By InvitationNA

The Role of Vitamin D in Corneal Epithelial Barrier Function, Ocular Microbiome, Ocular Inflammation, and Visual Acuity of Children With Allergic Conjunctivitis

NCT05839938 · Allergic Conjunctivitis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 30, 2026Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment320

Start dateNov 2020

Last updatedJan 30, 2026

Condition

Allergic Rhinitis Due to Pollen Allergic Conjunctivitis Allergic Asthma

Locations shown

Universitätsklinikum Augsburg

Augsburg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 30, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions